.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Chubb
Novartis
McKesson
Daiichi Sankyo
Express Scripts
Dow
Colorcon
Moodys

Generated: September 26, 2017

DrugPatentWatch Database Preview

FAMVIR Drug Profile

« Back to Dashboard

Which patents cover Famvir, and what generic Famvir alternatives are available?

Famvir is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in FAMVIR is famciclovir. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the famciclovir profile page.

Summary for Tradename: FAMVIR

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list78
Clinical Trials: see list4
Patent Applications: see list4,309
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FAMVIR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FAMVIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-001Apr 26, 1996► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-003Dec 11, 1995► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
Novartis
FAMVIR
famciclovir
TABLET;ORAL020363-002Jun 29, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for FAMVIR

Drugname Dosage Strength RLD Submissiondate
famciclovirTablets125 mg, 250 mg and 500 mgFamvir12/28/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Medtronic
Healthtrust
QuintilesIMS
Teva
Novartis
Boehringer Ingelheim
Chinese Patent Office
Chubb
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot